Nicholas Hobson, CEO of Fenner Dunlop, is to leave the company for medical reasons, the company has announced.
Hobson has been on leave to receive medical treatment since the beginning of the year but has now stepped down from the board with immediate effect and will leave the group after serving his notice period.
During the notice period, he will be on garden leave to allow continued medical treatment.
Mark Abrahams, who has led the company at executive chairman since January and previously served as CEO, has agreed to step back into the role of CEO.
Consequently, he will relinquish his role as Chairman of the Board, with Vanda Murray agreeing to step in as acting Non-Executive Chair.
Edited by Jonathan Rowland.